Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL002519

Drug Information
NameRigosertib
CompanyOnconova Therapeutics
IndicationAML
[ICD9: 205.0   ICD10: C92.0]
Phase I/II    
CLL
[ICD9: 204.1   ICD10: C91.1]
Phase II    
Lymphoma
[ICD9: 202.8   ICD10: C81-C96]
Phase II    
Myelodysplastic syndromes
[ICD9: 238.7   ICD10: D46]
Phase III    
Myelodysplastic syndromes (intravenous) (see also lymphoma, ovarian, pancreatic)
[ICD9: 183, 202.8, 238.7   ICD10: C56, C81-C96, D46]
Phase III    
Ovarian CancerPhase II    
Pancreatic CancerPhase II/III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C21H25NO8S/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)1
3-14-5-6-18(28-2)17(9-14)22-12-21(23)24/h5-11,22H,12-13H2,1-4H3,(
H,23,24)/b8-7+
InChIKeyOWBFCJROIKNMGD-BQYQJAHWSA-N
Canonical SMILESCOC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O    
Isomeric SMILESCOC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)O
FormulaC21H25NO8S
PubChem Compound IDCID 6918736.
TargetPlk1
c-akt



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543